Google-backed 23andMe is at the forefront of the direct-to-consumer DNA test kit boom. There are concerns about how health insurers may use the information to deny coverage. But there's another big insurance wrinkle: life insurance policies.
Russian President Vladimir Putin has one big weakness in his master plan to dominate the world stage: an aging oil economy that lacks innovation and globally competitive sectors.
Tesla announced this week that, for the first time, any car buyer can put in a purchase order for a Model 3, but auto-market experts say there are reasons for consumers to think twice, from price to tax rebates.
The Trump administration shocked the World Health Organization by mixing politics with breastfeeding, but there is no debate. Baby formula cannot match the health benefits of mother's milk.
Biogen's big success in a new Alzheimer's drug trial wasn't just a win for the company. It comes after years of failures with every drug tested for dementia and growing doubts about the drug industry's narrow focus on amyloid proteins.
Consumer DNA testing companies are rushing in to help immigrant parents reunite with detained children at the border, but there are privacy risks and questions about DNA ownership.
Kate Spade's simple yet fun design sensibility and quirky all-American style leaves an indelible mark on fashion, according to the CEO of Bloomingdale's and others, defying her tragic end.
Museum attendance is better than ever, thanks to the way technology is revolutionizing the consumption of art.
This startup is trying to use the shortage of hotel rooms along Monday's eclipse path to its advantage.